New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 11, 2012
19:02 EDTACMP, MCP, MPEL, WMB, GEOS, AET, EXAR, HBIO, DDOn The Fly: After Hours Movers
UP AFTER GUIDANCE: DuPont (DD), up 2.2% after saying it sees FY12 EPS at high end of previous guidance range... Aetna (AET), up 1.5% after backing FY12 EPS view... ALSO HIGHER: Melco Crown Entertainment (MPEL), up 2.8% after a Sterne Agee note positively mentioned the company's Macau casino operations... Harvard Bioscience (HBIO), up 5% after announcing one of its subsidiaries filed for an IPO... DOWN AFTER EARNINGS: Geospace Technologies (GEOS), down 11%... ALSO LOWER: Molycorp (MCP), down 7.7% after announcing its CEO was leaving the company... Exar (EXAR), down 7% after announcing the termination of its CFO... Williams (WMB) after announcing it was taking a $2.4B stake in Access Midstream Partners (ACMP).
News For DD;AET;MPEL;HBIO;GEOS;MCP;EXAR;WMB;ACMP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 13, 2015
09:44 EDTWMBMLPs that could trade up on Williams, Williams Partners news, says Credit Suisse
Credit Suisse said Plains GP Holdings (PAGP), Targa Resources (TRGP), NuStar (NSH), Western Gas Equity (WGP) could trade up on the Williams (WMB)/Williams Partners (WPZ) merger news.
09:21 EDTEXARExar takeout possible at $12-$13 per share, says Cowen
Cowen noted Exar is exploring strategic alternatives and believes a company sale could result in the $12-$13 range. The firm also thinks Exar could decide to shed its data compression business and build analog/mixed signal scale. Cowen has an Outperform rating and $13 price target on Exar.
09:21 EDTWMBOn The Fly: Pre-market Movers
Subscribe for More Information
08:51 EDTDDTrian says 'appears Trian nominees not elected to DuPont board'
Trian Fund Management, L.P., one of the largest stockholders of E. I. du Pont de Nemours and Company, which beneficially owns approximately 24.6 million DuPont shares, said it appears that the Trian nominees were not elected to the DuPont Board at todayís Annual Meeting of Stockholders. Trian issued the following statement: "Trianís involvement in DuPont over the past two years has created substantial value for all stockholders. We are proud of the quality of our analysis and the role we have played as a positive change agent at DuPont. Since we first invested in mid-2013, DuPont has upgraded its Board of Directors, authorized a $5 billion share buyback, begun a long-overdue cost cutting initiative, improved the design of its executive compensation program, and announced the separation of Chemours with a $4 billion return of capital. We donít believe these actions would have happened without our involvement. The vote was close. We greatly appreciate the support we received from the vast majority of institutional stockholders and mutual funds as well as the leading proxy advisory firms, who all recognize the need for change at DuPont. DuPontís Board and management team have staked their reputations on executing the Companyís current strategy. Our efforts have created appropriate pressure to prove this strategy can actually deliver high quality and consistent earnings growth. Regardless of the voting results, we believe that going forward, DuPont stockholders will be less tolerant of continued missed earnings guidance, extraordinary charges, value-destructive acquisitions and divestitures, executive compensation that is not aligned with performance, and operating metrics such as revenue growth and margins that fail to meet DuPontís own targets. We will continue to closely monitor DuPontís performance.Ē
08:31 EDTDDDuPont seen winning close proxy fight, CNBC's Faber reports
Subscribe for More Information
08:29 EDTDDDuPont seen winning proxy fight, CNBC's Faber reports
Subscribe for More Information
07:21 EDTWMBWilliams Partners jumps 14.8% to $54.41 after deal to be acquired by Williams
Subscribe for More Information
07:13 EDTWMBWilliams says combined entity will have 'strong' investment grade credit ratings
Subscribe for More Information
07:12 EDTWMBWilliams sees Williams Partners acquisition closing in fall of 2015
Subscribe for More Information
07:10 EDTWMBWilliams to acquire all public equity of Williams Partners
Subscribe for More Information
07:06 EDTWMBWilliams to acquire all public equity of Williams Partners
Subscribe for More Information
May 12, 2015
16:14 EDTEXARExar to undertake comprehensive review of strategic alternatives
Exar announced that its Board of Directors has unanimously decided to undertake a comprehensive review of strategic alternatives to enhance value for stockholders. Exar intends to conduct a thorough review and evaluation of strategic alternatives. Cowen and Company, LLC is acting as financial advisor, and O'Melveny & Myers LLP is acting as legal counsel, to Exar in connection with its review of strategic alternatives. "Following a detailed evaluation over the past several months, our Board of Directors has determined that it is prudent to undertake a wide review of strategic options to see which alternatives provide the best means to maximize stockholder value," said Mr. DiNardo. "Regardless of the outcome of the strategic alternatives review, the entire Exar team remains fully committed to meeting the needs of our customers and continuing to provide industry-leading solutions."
16:13 EDTEXARExar sees Q1 EPS 10c-12c, consensus 12c
Subscribe for More Information
16:11 EDTEXARExar reports Q4 EPS 11c, consensus 11c
Subscribe for More Information
13:03 EDTAETAetna repeats view of FY15 operating EPS $7.20-$7.40, consensus $7.38
Subscribe for More Information
11:53 EDTAETAnalyst predicts large transaction 'imminent' for Aetna
Subscribe for More Information
10:04 EDTAETHigh option volume stocks
Subscribe for More Information
09:53 EDTAETAetna merger with Cigna or Humana likely 'imminent,' says Leerink
Subscribe for More Information
06:13 EDTWMBWilliams files automatic mixed securities shelf
Subscribe for More Information
05:26 EDTDDDuPont issues statement regarding Trian's statements
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use